ASXL1 and neoplasm: Supporting the tumor suppressive effects of TXNIP and MAGI1, we found that knockdown of TXNIP or MAGI1 in ASXL1+/− K562 cells led to increased proliferation (Fig. S12D and S12G) and higher cell viability under serum deprivation (Fig. S12E and S12H).